VVP
GH icon

Venture Visionary Partners’s Guardant Health GH Stock Holding History

Venture Visionary Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50
Closed -$2.02K – 885
2022
Q2 		$2.02K Buy
+50
New +$2.48K ﹤0.01% 1536

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Venture Visionary Partners's GH Position: Q3 2022 in Review

Venture Visionary Partners sold out of Guardant Health (GH) in Q3 2022, closing a stake of 50 shares — an estimated $2.02K sold.

Venture Visionary Partners first reported a position in GH in Q2 2022 and held it in 1 quarter. The position peaked at $2.02K in Q2 2022. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

  • Venture Visionary Partners reported no remaining Guardant Health position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 50 Guardant Health shares in Q3 2022, an estimated $2.02K.
  • Venture Visionary Partners first reported a position in Guardant Health in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Guardant Health position peaked at $2.02K in Q2 2022.
  • 328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.